FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

11753311000001101: Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2879971000001111 Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2879981000001113 Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Is a Gestodene 75microgram / Ethinylestradiol 30microgram tablets 63 tablet true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Is pack of Katya 30/75 tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has active ingredient Gestodene false Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has AMP Katya 30/75 tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Gestodene true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start